Sierra Fedelem may look like any other 20-month-old, but her parents are doing everything they can to make sure her life is just like that of any other healthy human being.
Stem cell research has stirred quite the controversy in the United States, and though the current administration’s recent policy reversal on the issue could open the markets to treatments and commercialization, it’s still an option unavailable for American patients, like Sierra, unless they’re willing to travel across the world.
“The first time the neurologist said, ‘No, you don’t realize it, she’s never going to be able to walk, talk and
Image via Wikipedia
A clampdown on unproven and potentially unsafe stem cell research is being called for by an expert group.
Bionet, a group of expert Chinese and European doctors, lawyers and bioethicists, says countries throughout the world must develop more effective regulation for this emerging science (…)
They had provided a wealth of anecdotal evidence about their concerns that stem cell research was being moved too rapidly into clinical practice without proper study.
He said: “The key is informed consent. Doctors should be able to tell the patient about the short-term and long-term prognosis and the things we don’t know about the
Adult Stem Cell Group Having A Rally
A group of patients who have been helped by stem cell research using Adult Stem Cells have formed a group called the Stem Cell Awareness Association. This group is growing fast with prospective stem cell patients and even US doctors joining the movement. They will be holding a Stem […]
Stem Cell Research Helps Blind Girl See
Hayley Pelletier had been legally blind since birth due to her Optic Nerve Hypoplasia. However, thanks to the wonders of stem cell research using Adult Stem Cells, these days Hayley can now see and in the words of her mother “Basically, her whole quality of life was just […]
A study conducted by Beike Biotechnology Company ( http://www.beikebiotech.com ) in conjunction with physicians and researchers at two Chinese hospitals, documents the effectiveness of cord blood-derived stem cells in treating primary biliary cirrhosis (PBC). The study, which was published in the April 2012 issue of the Stem Cell Discovery, was the first of its kind. Researchers noted that additional clinical trials would be required before stem cells can become an accepted therapy for liver cirrhosis.
Prof. Jin-hui Yang, Director of the Department of Hepatology in the 2nd Affiliated Hospital of Kunming Medical College stated, “Given the severity of liver cirrhosis